Fund Description
The investment seeks investment results that correspond generally, before fees and expenses, to the performance of the GS Risk-Adjusted Return U.S. Large Cap Index. The fund will invest at least 80% of its total assets in the securities that comprise the index. The index is designed to reflect the performance of a hypothetical portfolio of U.S. stocks that are anticipated to have the highest risk-adjusted returns based on a methodology (the "Methodology") developed by Goldman, Sachs & Co. The Methodology selects a target of 50 stocks for inclusion in the index from a subset of U.S. equity securities within the Russell 1000® Index. It is non-diversified.
Fund Snapshot Updated 05.21.2013
| Previous Close | $29.48 | Expense Ratio | 0.55% |
| YTD Return | 19.4% | Avg. 30-Day Volume | 336 |
| 1-Year Return | 0.0% | Market Cap | Loading... |
| Bid | $29.48 | Shares Outstanding | 400,000 |
| Ask | $29.50 | Dividends | $0.27 |
| Top 10 Holdings | |
|---|---|
| Vertex Pharmaceuticals Inc (VRTX) | 3.30% |
| Micron Technology Inc (MU) | 3.07% |
| Delta Air Lines Inc Del (DAL) | 3.06% |
| Warner Chilcott Plc Ireland (WCRX) | 2.87% |
| Nu Skin Enterprises Inc (NUS) | 2.25% |
| Harman Intl Inds Inc (HAR) | 2.20% |
| Csx Corp (CSX) | 2.18% |
| Microsoft Corp (MSFT) | 2.17% |
| Ford Mtr Co Del (F) | 2.16% |
| Gnc Hldgs Inc (GNC) | 2.15% |
| % of Total Holdings | 25.40% |
